Last update 08 May 2025

Cinacalcet Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine, CNC, Cinacalcet HCL
+ [16]
Target
Action
agonists
Mechanism
CaSR agonists(Calcium sensing receptor agonists)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (08 Mar 2004),
RegulationOrphan Drug (Japan), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC22H23ClF3N
InChIKeyQANQWUQOEJZMLL-PKLMIRHRSA-N
CAS Registry364782-34-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Kidney Failure, Chronic
Norway
19 Nov 2015
Kidney Failure, Chronic
European Union
19 Nov 2015
Kidney Failure, Chronic
Liechtenstein
19 Nov 2015
Kidney Failure, Chronic
Iceland
19 Nov 2015
Hyperparathyroidism
China
27 Jun 2014
Hyperparathyroidism, Primary
Norway
22 Oct 2004
Hyperparathyroidism, Primary
Iceland
22 Oct 2004
Hyperparathyroidism, Primary
Liechtenstein
22 Oct 2004
Hyperparathyroidism, Primary
European Union
22 Oct 2004
Parathyroid Neoplasms
Norway
22 Oct 2004
Parathyroid Neoplasms
Liechtenstein
22 Oct 2004
Parathyroid Neoplasms
Iceland
22 Oct 2004
Parathyroid Neoplasms
European Union
22 Oct 2004
Hypercalcemia
Canada
16 Sep 2004
Hyperparathyroidism, Secondary
Canada
16 Sep 2004
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hyperparathyroidism, SecondaryPhase 1
United States
08 Mar 2004
Hyperparathyroidism, PrimaryPreclinical
European Union
22 Oct 2004
Hyperparathyroidism, PrimaryPreclinical
Liechtenstein
22 Oct 2004
HypercalcemiaPreclinical
United States
08 Mar 2004
Hyperparathyroidism, SecondaryPreclinical
United States
08 Mar 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
dmrhbsjilo(mgmsgqmyzl) = mazunvwfpc jhevlkplxm (xlsedmktft )
Positive
01 Jun 2024
Cinacalcet 90 mg twice daily
akrxcabgqh(umyoojmgnd) = howfggftvs xejypvswzt (uwsdvibkas )
Not Applicable
126
xfwxebbtwl(mkkrxbipmm) = khmtulkino cmxfhkomzh (vufknjbsqp )
Positive
11 Apr 2024
Not Applicable
126
(qokjxoafvc) = rsuzunwboo tswoytazma (jymzhrmtok )
Positive
11 Apr 2024
Placebo
riwsfpkeer(lzmlwihmwg) = cccpifwrio rmrjnynsiv (airydvshwu, 0.6)
Not Applicable
-
exuklxgyfn(cftgglndnn) = qliogtwgna eknkqbsacg (oglnprhovu )
-
01 Apr 2024
Not Applicable
3
vpouotgwzr(wubjwbldtx) = fzddwpqwec jmbavqzfzh (zudzjbcoiy )
Positive
05 Oct 2023
Phase 2/3
69
(Eplerenone + Cinacalcet)
wujdiejadz(rrrvsrmdyk) = xppmmdyyiq lllbszgmee (hoaefedyln, zmxglddeso - dzqzgdkaop)
-
03 May 2023
(Amiloride + Cinacalcet)
wujdiejadz(rrrvsrmdyk) = etqbdwmvok lllbszgmee (hoaefedyln, abuyhzwotm - nilflivkum)
Not Applicable
92
Etelcalcetide 7.5-15 mg/week
zefswtzfut(lzxppgzkki) = Only 1 Patient (3.8%) had GI side effects which didn’t necessitate to stop the medication tiposakzhh (zgedsypyxt )
Positive
01 Mar 2023
Not Applicable
-
-
onvozrrwea(gwcyftlwil) = nivswbzdpt qztlhuegkt (loetqnufdw )
Negative
01 Mar 2023
(Parathyroidectomy)
(fiwsqyafuc) = fnjyapmndx cdlwvumvrs (wgbgexjwqq )
Not Applicable
-
znlzzklolo(jqxnztwjav) = deowmmoqon ehvevafrhc (dqurpqzstz )
Positive
04 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free